Consequently, it is not surprising that the inhibition of c-Src promoted by Cx43 reduces the cell cycle [11, 19], glucose uptake [24, 25] or glioma stem cell phenotype [11, 19] (for a review, see [26]). The gene discussed is SRC; the disease is central nervous system cancer.